OR:NYSEOR Royalties Inc. Analysis
Data as of 2026-06-17 - not real-time
$36.04
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
OR Royalties is trading at $36.04, just below the 20‑day SMA of 35.23 and well above its 200‑day SMA of 37.67, signaling a short‑term bearish bias despite a bullish MACD histogram. The RSI sits around 51, indicating neutral momentum, while volume is on an increasing trend and the 30‑day volatility exceeds 54%, suggesting sizable price swings. The stock’s beta of 1.32 amplifies market moves, and the max drawdown of roughly 34% underscores the downside risk in a volatile gold‑linked sector.
Fundamentally, OR boasts extraordinary margins (gross >96%, operating >85%) and a revenue growth rate of 87%, with a clean balance sheet (debt‑to‑equity 0.315) and strong ROE of 19%. However, the DCF‑derived fair value of $16.34 is less than half the current price, implying the market is pricing a substantial premium. Analysts rate the stock as a “buy” with a median target of $50.5, translating to a potential upside of over 30% from today’s level, while the Fear & Greed Index at 88.5 reflects extreme market optimism.
Fundamentally, OR boasts extraordinary margins (gross >96%, operating >85%) and a revenue growth rate of 87%, with a clean balance sheet (debt‑to‑equity 0.315) and strong ROE of 19%. However, the DCF‑derived fair value of $16.34 is less than half the current price, implying the market is pricing a substantial premium. Analysts rate the stock as a “buy” with a median target of $50.5, translating to a potential upside of over 30% from today’s level, while the Fear & Greed Index at 88.5 reflects extreme market optimism.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish trend direction with price near resistance
- High short‑term volatility and beta
- Bullish MACD histogram offering limited upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and ultra‑high profit margins
- Low leverage and solid cash generation
- Analyst consensus buy with median target $50.5
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Royalty model provides exposure to gold price upside
- Sustainable cash flow and high ROE
- Sector tailwinds and limited dilution risk
Key Metrics & Analysis
Financial Health
Revenue Growth87.30%
Profit Margin78.09%
P/E Ratio26.9
ROE18.91%
ROA10.28%
Debt/Equity0.32
P/B Ratio4.6
Op. Cash Flow$271.4M
Free Cash Flow$82.3M
Technical Analysis
TrendBearish
RSI51.0
Support$31.40
Resistance$38.23
MA 20$35.23
MA 50$37.38
MA 200$37.67
MACDBullish
VolumeIncreasing
Fear & Greed Index88.55
Valuation
Fair Value$16.34
Target Price$48.00
Upside/Downside33.20%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.32
Volatility54.54%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.